6-ethyl-4,4-dimethyl-2-cyclohexen-1-one

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 6-ethyl-4,4-dimethyl-2-cyclohexen-1-one
• 化学式: C₁₀H₁₆O
• 分子量: 152.236
• InChiKey: UANRDENBBJMXAW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.57
• 重原子数：
  11.0
• 可旋转键数：
  1.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  17.07
• 氢给体数：
  0.0
• 氢受体数：
  1.0

反应信息

• 作为反应物：
  描述：

  6-ethyl-4,4-dimethyl-2-cyclohexen-1-one 在 lithium 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 1.0h， 生成 2'‐allyl‐6,6‐dimethyl‐5,6‐dihydro‐[1,1'‐biphenyl]‐3(4H)‐one
  参考文献：
  名称：

  AlCl3 促进的 Conia-Ene 相关的 α,ω-二烯酮环化和未活化环丙烷的 1,2- 或 1,3-氢烯基化

  摘要：

  在ε-、δ-或η-位具有未活化烯烃的α,β-不饱和烯酮经历氯化铝促进的Conia-ene相关环化，以通常良好的产率提供不饱和十酮或六氢茚酮。在此过程中，环丙烷可用作烯烃替代物，通过 1,2- 或 1,3- 加氢烯基化反应，产生相同的双环产物，但效率略有提高。该方法提供了获得全系列双环或三环烯酮合成子的途径，其中一些可能用作气味剂或用于生物活性分子的合成。

  DOI：

  10.1002/adsc.202300317

文献信息

• Arginase Inhibitors and Their Therapeutic Applications
  申请人：OncoArendi Therapeutics S.A.

  公开号：US20170319536A1

  公开（公告）日：2017-11-09

  Disclosed are small molecule therapeutic compounds that are potent inhibitors of arginase 1 and arginase 2 activity. Also disclosed are pharmaceutical compositions comprising the compounds, and methods for using the compounds for treating or preventing a disease or condition associated with arginase activity.

  揭示了一种小分子治疗化合物，它们是较强的精氨酸酶1和精氨酸酶2活性抑制剂。还揭示了包含这些化合物的药物组合物，以及使用这些化合物治疗或预防与精氨酸酶活性相关的疾病或状况的方法。
• 4,4-dimethyl-decal-1-one or -1-OL derivatives as perfuming ingredients
  申请人：Moretti Robert

  公开号：US08697626B2

  公开（公告）日：2014-04-15

  The present invention relates to use of a compound of formula (I) in the form of any one of its stereoisomers or a mixture thereof, and wherein the dotted lines represent a single or double bond, and at least one of said dotted lines represents a double bond; n represents simultaneously 0, in which case the oxygen atom is bounded to the cyclanic carbon atom by a double bond, or 1, in which case the oxygen atom is bounded to the cyclanic carbon atom by a single bond, each R represents a hydrogen atom or a methyl group; R1 represents a hydrogen atom or a methyl or ethyl group; and R2 represents a hydrogen atom or a methyl or ethyl group; and the groups R, R1 and R2 have in total, i.e. all together account for 1 to 4 carbon atoms; as perfuming ingredient, for instance to impart odor notes of the woody type together with balsamic/spicy and/or musky notes.

  本发明涉及使用式(I)的化合物，其形式为其任一立体异构体或其混合物，其中虚线表示单键或双键，至少其中一条虚线表示双键；n同时表示0，此时氧原子通过双键与环烷基碳原子结合，或1，此时氧原子通过单键与环烷基碳原子结合，每个R表示氢原子或甲基基团；R1表示氢原子或甲基或乙基基团；R2表示氢原子或甲基或乙基基团；且基团R，R1和R2总共具有1至4个碳原子，作为香料成分，例如与香脂/辛辣和/或麝香的气味注解一起赋予木质类型的气味注解。
• Inhibitory or blocking agents of molecular generating and/or inducing functions
  申请人：——

  公开号：US20040224926A1

  公开（公告）日：2004-11-11

  A method for inhibiting or blocking molecular generating and/or inducing functions of molecules using an inhibitory or blocking agent of the formula: 1 wherein R 1-6 and A are as defined herein.

  一种通过使用式子1中的抑制剂或阻断剂来抑制或阻断分子生成和/或诱导功能的方法，其中R1-6和A的定义如本文所述。
• Inhibitory or blocking agents of molecular generating and/or/ inducing functions
  申请人：Koyama Shozo

  公开号：US20080200558A1

  公开（公告）日：2008-08-21

  A method for inhibiting or blocking molecular generating and/or inducing functions of molecules using an inhibitory or blocking agent of the formula: wherein R1-6 are as defined herein.

  一种抑制或阻断分子生成和/或诱导功能的方法，使用式子为：其中R1-6如本文所定义的抑制剂或阻断剂。
• DEPRESSANT OF FUNCTIONS DEVELOPED BY MOLECULE
  申请人：Koyama, Shozo

  公开号：EP0780122A1

  公开（公告）日：1997-06-25

  An agent for depressing and inhibiting the functions developed by the multidimensional structure (conformation) of a molecule through a nonenzymatic reaction. Examples thereof include a compound having a fundamental molecular structure represented by general formula (a), and other agents containing the compound, a derivative thereof or an acid-addition salt thereof as the active ingredient, such as antibacterial agent, antifungal agent, antiviral agent, germicide/disinfectant, anticancer drug, blood-clotting/fibrinolytic system depressant or inhibitor, antigen-antibody reaction depressant, organ-tissue preservative or antiseptic for food, etc., spermatocide or contraceptive for external use, thrombolytic agent, sugar-chain conformation modifier, arteriosclerosis preventive, improver for (lipid, sugar or protein) metabolism, wound healing agent, epithelialization accelerator, depressant of function development of bioactive substances (such as enzyme, peptide and gene), depolymerizer, surface activity improver, phase transfer agent or phase transfer improver, micro-phase separate structure improver, plasticizer or plasticity improver, copolymerizing agent or copolymerization improver, polymerization regulator or polymerization regulator/improver, stabilizer or stabilization improver, noncrystallizer or noncrystallizability improver, fluidity improver, flexibilizer or flexibilization improver, oxidation inhibitor antioxidant, modifier or improver of the fluorescence wavelength or excitation wavelength of dye, paint, pigment or colorant, improver of properties or functions of low-molecular-weight substance, improver of properties or functions of high-molecular-weight substance, and improver of properties of high-molecular-weight composite material or functional high-molecular-weight composite material.

  一种通过非酶促反应抑制和抑制由分子的多维结构（构象）形成的功能的制剂。例如，具有通式（a）所代表的基本分子结构的化合物，以及含有该化合物、其衍生物或其酸加成盐作为活性成分的其他制剂，如抗菌剂、抗真菌剂、抗病毒剂、杀菌剂/消毒剂、抗癌药、凝血/纤溶系统抑制剂或抑制剂、抗原-抗体反应抑制剂、器官组织防腐剂或食品防腐剂等、外用杀精剂或避孕药、溶栓剂、糖链构象调节剂、动脉硬化预防剂、（脂质、糖或蛋白质）新陈代谢改良剂、伤口愈合剂、上皮细胞加速剂、生物活性物质（如酶、肽和基因）功能开发抑制剂、解痉剂、抗原抗体反应抑制剂、器官组织防腐剂或食品防腐剂等、肽和基因）的功能开发抑制剂、解聚剂、表面活性改良剂、相转移剂或相转移改良剂、微相分离结构改良剂、增塑剂或可塑性改良剂、共聚剂或共聚改良剂、聚合调节剂或聚合调节剂/改良剂、稳定剂或稳定改良剂、非结晶剂或非结晶性改良剂、流动性改良剂、增挠剂或增挠改良剂、 氧化抑制剂、抗氧化剂、染料、涂料的荧光波长或激发波长的调节剂或改良剂、颜料或着色剂、改良剂、染料、涂料、颜料或着色剂、染料、涂料、颜料或着色剂的荧光波长或激发波长的调节剂或改良剂；低分子量物质的特性或功能改良剂；高分子量物质的特性或功能改良剂；以及高分子量复合材料或功能性高分子量复合材料的特性改良剂。